Document is current
Any future updates will be listed below
-
Authors
Reina-Campos, Miguel
Monell, Alexander https://orcid.org/0000-0002-5399-2205
Ferry, Amir https://orcid.org/0000-0003-2884-083X
Luna, Vida https://orcid.org/0000-0002-6300-8128
Cheung, Kitty P.
Galletti, Giovanni https://orcid.org/0000-0001-6613-2354
Scharping, Nicole E.
Takehara, Kennidy K.
Quon, Sara https://orcid.org/0000-0003-3860-3491
Challita, Peter P. https://orcid.org/0009-0004-8634-031X
Boland, Brigid
Lin, Yun Hsuan https://orcid.org/0009-0008-5997-9109
Wong, William H.
Indralingam, Cynthia S.
Neadeau, Hayley https://orcid.org/0009-0004-5011-5989
Alarcón, Suzie
Yeo, Gene W. https://orcid.org/0000-0002-0799-6037
Chang, John T. https://orcid.org/0000-0003-0873-6218
Heeg, Maximilian https://orcid.org/0000-0002-9594-1377
Goldrath, Ananda W. https://orcid.org/0000-0002-5900-508X
- License Information
-
More Information
Article History
Received: 29 February 2024
Accepted: 27 November 2024
First Online: 22 January 2025
Competing interests
: M.R.-C. is a co-founder, scientific adviser and board member of TCura Bioscience, Inc. A.F. is a co-founder, CEO and board member of TCura Bioscience. B.B. receives consulting fees from Bristol Myers Squibb and Pfizer and research grants from Merck and Gilead. A.W.G. is a co-founder of TCura Bioscience, Inc. and serves on the scientific advisory board of ArsenalBio and Foundery Innovations. The other authors declare no competing interests.
